Hologic of Bedford, MA has announced that the FDA's Radiological Devices Panel will be reviewing the company's Selenia Dimensions 3-D digital mammography tomosynthesis system. The device takes many low energy X-ray shots from different angles and reconstructs a 3D image of the breast. Hologic's Selenia Dimensions technology is already available in most of the rest of the world, but FDA's regulatory bureaucracy will only meet to discuss the system in September.
No comments:
Post a Comment